Poglin Tablets 5 mg (Dapagliflozin Propanediol Hydrate)

Adult dose

The recommended dosage of this medication for monotherapy and combination therapy is 10 mg once daily. For initial combination therapy, administer 5 mg or 10 mg once daily. This medication can be taken orally at any time during the day, regardless of meal intake. The tablets must be swallowed whole.

Child dose

The efficacy and safety in children under 18 years have not been established. There is no dosage for this medication.

This medication should not be used in specific patients. Individuals who are allergic to its active ingredients or excipients, patients with type 1 diabetes, or those with diabetic ketoacidosis should not take this medication. Additionally, patients with lactose intolerance or hereditary lactose absorption disorders should also avoid this drug. Use is prohibited in dialysis patients. In patients with reduced fluid volume or impaired kidney function, this medication should be used cautiously. This drug may lower blood pressure and has a risk of causing acute kidney injury; therefore, kidney function and blood pressure should be monitored regularly. Extra caution is necessary especially in elderly patients or those taking diuretics. During the use of this medication, genital and urinary tract infections may occur; thus, immediate treatment is required if any symptoms of infection appear. Hypoglycemic symptoms may also occur, so when taken with insulin or sulfonylureas, blood sugar should be frequently monitored and dosage adjustments made as necessary. This drug can cause a serious metabolic disorder known as ketoacidosis, so if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, seek medical consultation immediately. Ketoacidosis can occur even if blood sugar levels are within the normal range, so caution is needed. It is advisable that pregnant or breastfeeding women do not take this medication, and it should be discontinued immediately if pregnancy is confirmed. In cases of overdose, there is no specific antidote available, so appropriate treatment should be administered according to symptoms, and rapid management is needed if dehydration or hypotension symptoms appear. While this medication does not significantly impact driving or operating machines, caution is advised when taken with drugs that increase the risk of hypoglycemia. Finally, this medication should be kept out of the reach of children and stored in its original container to maintain quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rash with high fever, blistering, peeling skin, pain in oral/ocular mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, breathing problems, yellowing of the skin or eyes (jaundice), profound malaise, liver abnormalities (jaundice), sudden and

Mild side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia, dry mouth, dizziness, constipation, back pain, dysuria, polyuria, nocturia, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, increased serum urea, weight loss, weakness, pain, edema, itching, hives, sweating, chest pain, fatigue, headache,

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Yellow, round, film-coated tablets with a biconvex shape

Package unit

28 tablets/box [7 tablets/PTP x 4]